1-4 of 4
Harald Gschaidmeier, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase II Study of Single-Agent Imatinib Versus Chemotherapy Therapy in Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Including Analysis of Resistance Patterns.

Heike Pfeifer, MD, Oliver G. Ottmann, MD, Nicola Goekbuget, MD, Lydia Wunderle, MD, Patrick Brueck, MD, Aristoteles Giagounidis, MD, Michael Stelljes, MD, Andreas Hochhaus, MD, Harald Gschaidmeier, MD, Dieter Hoelzer, MD, Barbara Wassmann, MD
Journal: Blood
Blood (2005) 106 (11): 1824.
https://doi.org/10.1182/blood.V106.11.1824.1824
Published: 2005
Journal Articles

Pattern and Evolution of BCR-ABL Kinase Domain Mutations in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Developing Resistance to Imatinib.

Heike Pfeifer, MD, Barbara Wassmann, MD, Anni Pavlova, MD, Martin Mueller, MD, Lydia Wunderle, MD, Patrick Brueck, MD, Johannes Oldenburg, MD, Andreas Hochhaus, MD, Harald Gschaidmeier, MD, Dieter Hoelzer, MD, PhD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2005) 106 (11): 147.
https://doi.org/10.1182/blood.V106.11.147.147
Published: 2005
Journal Articles

A Multicenter Phase I/II Trial of the Combination of Imatinib Mesylate with Mitoxantrone/Etoposide and Cytarabine in Patients with CML in Myeloid Blast Crisis: A Trend to a Longer Survival in Patients Receiving More Aggressive Treatment Schedules.

Stefan Fruehauf, MD, Julian Topaly, MD, Eike C. Buss, MD, Thomas Fischer, MD, Bertold Emmerich, MD, Harald Gschaidmeier, MD, Rudiger Hehlmann, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2004) 104 (11): 2929.
https://doi.org/10.1182/blood.V104.11.2929.2929
Published: 2004
Journal Articles

Imatinib Given Concurrently with Induction Chemotherapy Is Superior to Imatinib Subsequent to Induction and Consolidation in Newly Diagnosed Philadelphia-Positive Acute Lymphoblastic Leukemia (PH+ALL).

Oliver G. Ottmann, MD, Barbara Wassmann, MD, Heike Pfeifer, MD, Nicola Goekbuget, MD, Gesine Bug, MD, Patrick Brueck, MD, Anja Binckebanck, Harald Gschaidmeier, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2004) 104 (11): 685.
https://doi.org/10.1182/blood.V104.11.685.685
Published: 2004